Jennifer K. Moses Insider Profile
4 Followers
Jennifer K. Moses, Director at Viridian Therapeutics, holds ― shares in Viridian Therapeutics (Ticker: VRDN), holds 57.82K shares in G1 Therapeutics (Ticker: GTHX).
Jennifer K. Moses's Trading History
| GTHXG1 Therapeutics | Jan 05, 2023 | ― | Uninformative Buy | ― | $413.41K | |
| VRDNViridian Therapeutics | ― | Director | ― | ― |
You May Also Like
Jennifer K. Moses insider profile FAQ
What is the percentage of profitable transactions made by Jennifer K. Moses?
The percentage of profitable transactions made by Jennifer K. Moses is 100%.
What is the average return per transaction made by Jennifer K. Moses?
The average return per transaction made by Jennifer K. Moses is 45.90%.
What stocks does Jennifer K. Moses hold?
Jennifer K. Moses holds: VRDN, GTHX stocks.
What was Jennifer K. Moses's most profitable transaction?
Jennifer K. Moses’s most profitable transaction was an Informative Sell of GTHX stock on January 5, 2022. The return on the trade was 48.70%.
What is Jennifer K. Moses's role in Viridian Therapeutics?
Jennifer K. Moses's role in Viridian Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
